Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein

Area of Science:

• Computational biology and vaccinology
• Infectious disease research

Background:

• The COVID-19 pandemic necessitates vaccines effective against mutating SARS-CoV-2 strains.
• Existing vaccines may not offer optimal protection for specific populations like Indonesians.
• A gap exists in designing multiepitope vaccines for COVID-19 using immunoinformatics for the Indonesian demographic.

Purpose of the Study:

• To design a multiepitope-based vaccine for the Indonesian population against SARS-CoV-2.
• To utilize a comprehensive immunoinformatic approach for vaccine development.
• To predict and analyze key immunological components of the potential vaccine.

Main Methods:

• Selection of SARS-CoV-2 spike glycoprotein sequences from Indonesia (GISAID database).
• Prediction of T-cell epitopes (CD8+ CTL, CD4+ HTL), B-cell epitopes, and IFN-γ induction.
• In silico vaccine modeling, molecular docking, molecular dynamics, immune simulations, and plasmid vector design.

Main Results:

• The designed vaccine candidate is predicted to be antigenic, non-allergenic, and non-toxic.
• It is capable of inducing Interferon-gamma (IFN-γ) production.
• The vaccine demonstrated good stability in molecular dynamics and immune simulations, with an 86.29% population coverage in Indonesia.

Conclusions:

• A promising multiepitope vaccine model for COVID-19 has been designed for the Indonesian population.
• The in silico analysis indicates high potential efficacy and safety.
• Further experimental investigation of this vaccine model is recommended.